Pain Therapeutics, Inc. Stock Nasdaq
Equities
US69562K5065
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 150M 205M | Capitalization | 875M 1.2B |
---|---|---|---|---|---|
Net income 2024 * | -96M -131M | Net income 2025 * | - 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.83 x |
P/E ratio 2024 * |
-9.43
x | P/E ratio 2025 * |
-42.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.66% |
Managers | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 18-09-30 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 21-01-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 98-04-30 |
Robert Gussin
BRD | Director/Board Member | 86 | 03-02-28 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07-12-06 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |